Duct Cell Adenocarcinoma of the Pancreas
📧 Sign up to get email alerts when something new happens for Duct Cell Adenocarcinoma of the Pancreas.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial of gemcitabine, nab-paclitaxel, and KPT-330 in advanced pancreatic cancer completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2020-03-06Clinical Trial Update: Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating ipilimumab with gemcitabine in stage III–IV or recurrent pancreatic cancer that is unresectable; completed with res…